David S. Schilansky
Founder chez One Biosciences SAS
Provenance du réseau au premier degré de David S. Schilansky
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
21
| Public Company | Pharmaceuticals: Major | 21 |
16
| Public Company | Miscellaneous Commercial Services | 16 |
One Biosciences SAS
 One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France.
4
| Subsidiary | Biotechnology | 4 |
Home Biosciences SAS
 Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception.
3
| Holding Company | Biotechnology | 3 |
Vantiva Usa Shared Services, Inc.
 Vantiva Usa Shared Services, Inc. Electronics/AppliancesConsumer Durables Technicolor USA, Inc. manufactures and sells electronic products. It offers wide selection of radio, television, tablets, smart phones, laptop, home accessories, portable audio, and computer products. The company was founded in 1919 and is headquartered in Indianapolis, IN.
1
| Subsidiary | Electronics/Appliances | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à David S. Schilansky via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Chief Executive Officer | |
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Medical/Nursing Services | President Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VALLOUREC | Steel | General Counsel Corporate Officer/Principal | |
| STALLERGENES | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen International GmbH
 Ipsen International GmbH Industrial MachineryProducer Manufacturing Ipsen International GmbH manufactures and distributes furnaces and plant systems. Its products include sealed quench furnaces; chamber and multi-purpose chamber furnaces; horizontal and vertical furnaces; EcoFire system; HydroNit Sensor; HybridCarb; and EndoSave system. The firm also provides software processes such as Carb-o-Prof 4.0, AutoMag, Vacu-Prof, and Conti-Control. The company was founded by Harold Ipsen in 1957 and is headquartered in Kleve, Germany. | Industrial Machinery | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Chairman Investment Committee Member | |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Chief Operating Officer Corporate Officer/Principal | |
| London School of Economics & Political Science | College/University | Undergraduate Degree Undergraduate Degree | |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| ESSEC Business School | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree | |
| ESCP Europe Campus Paris | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
| École Nationale Supérieure des Mines de Paris | College/University | Graduate Degree Undergraduate Degree | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Chairman | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chairman Director/Board Member | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | President Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
| AgroParisTech | College/University | Graduate Degree Graduate Degree | |
| Institut d'Administration des Entreprises de Paris | College/University | Masters Business Admin Masters Business Admin | |
| Ipsen OOO | Chairman Chairman | ||
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Chairman | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Servier SAS
 Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| EUROAPI | Biotechnology | Director/Board Member Chairman |
Statistiques
Internationale
| France | 31 |
| Etats-Unis | 10 |
| Danemark | 3 |
| Royaume-Uni | 3 |
| Suisse | 3 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 13 |
| Health Services | 3 |
| Finance | 3 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 328 |
| Corporate Officer/Principal | 151 |
| Chairman | 81 |
| Independent Dir/Board Member | 73 |
| Undergraduate Degree | 43 |
Relations les plus connectées
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Antoine Papiernik | 48 |
| Jean-Luc Bélingard | 40 |
| Marc M. P. de Garidel | 31 |
| Stephan Christgau | 29 |
| Michel de Rosen | 28 |
| Didier Hoch | 24 |
| Rafaèle Elisabeth Tordjman | 23 |
| Mathieu Simon | 22 |
| Viviane Monges | 21 |
| Maïlys Ferrère | 21 |
| Claude Bertrand | 20 |
| Claire Giraut | 16 |
| Daniel Tassé | 16 |
| Julie O'Neill | 16 |
- Bourse
- Insiders
- David S. Schilansky
- Connexions Sociétés
